ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

BPCR Biopharma Credit Plc

0.878
0.00 (0.00%)
25 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Biopharma Credit Plc LSE:BPCR London Ordinary Share GB00BDGKMY29 ORD USD0.01
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.878 0.876 0.88 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Finance Services 135.74M 108.45M 0.0833 10.56 1.15B

BioPharma Credit PLC Director/PDMR Shareholding (0862V)

18/07/2018 6:00pm

UK Regulatory


Biopharma Credit (LSE:BPCR)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more Biopharma Credit Charts.

TIDMBPCR

RNS Number : 0862V

BioPharma Credit PLC

18 July 2018

BIOPHARMA CREDIT PLC

Notification of Transactions by

Persons Discharging Managerial Responsibilities and

Persons Closely Associated with them

 
 1.   Details of person discharging managerial responsibilities/person 
       closely associated with them 
 a)   Name                      Anita Hyman 
     ------------------------  -------------------------------------------- 
 2.   Reason for the notification 
     ---------------------------------------------------------------------- 
 a)   Position / status         Person Closely Associated with Harry 
                                 Hyman (Director of BioPharma Credit PLC) 
     ------------------------  -------------------------------------------- 
 b)   Initial notification      Initial notification 
       / amendment 
     ------------------------  -------------------------------------------- 
 3.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
     ---------------------------------------------------------------------- 
 a)   Name                      BioPharma Credit PLC 
     ------------------------  -------------------------------------------- 
 b)   LEI                       213800AV55PYXAS7SY24 
     ------------------------  -------------------------------------------- 
 4.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of 
       transaction; (iii) each date; and (iv) each place where 
       transactions have been conducted 
     ---------------------------------------------------------------------- 
 a)   Description                 Ordinary Shares of $0.01 each 
       of the financial            GB00BDGKMY29 
       instrument 
       Identification 
       Code 
     --------------------------  ------------------------------------------ 
 b)   Nature of the               Purchase of Shares (acquired as part 
       transaction                 of dividend reinvestment) 
     --------------------------  ------------------------------------------ 
 c)   Price(s) and                 Price(s)      Volume(s) 
       volume(s)                    GBP0.81527    25 
                                                 ---------- 
     --------------------------  ------------------------------------------ 
 d)   Aggregated information      N/A 
       - Aggregated 
       volume 
       - Price 
     --------------------------  ------------------------------------------ 
 e)   Date of the                 17.07.18 
       transaction 
     --------------------------  ------------------------------------------ 
 f)   Place of the                London Stock Exchange (XLON) 
       transaction 
     --------------------------  ------------------------------------------ 
 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHBLGDRCDBBGII

(END) Dow Jones Newswires

July 18, 2018 13:00 ET (17:00 GMT)

1 Year Biopharma Credit Chart

1 Year Biopharma Credit Chart

1 Month Biopharma Credit Chart

1 Month Biopharma Credit Chart

Your Recent History

Delayed Upgrade Clock